SCHEMBL438637

SCHEMBL438637

CCNc1ccc2c(=O)[nH][nH]c(=O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 4/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ PSEN1 P49768 1/20 0.46
▸ PSEN2 P49810 1/20 0.46
▸ APH1B Q8WW43 1/20 0.46
▸ NCSTN Q92542 1/20 0.46
▸ APH1A Q96BI3 1/20 0.46
▸ PSENEN Q9NZ42 1/20 0.46
▸ ELANE P08246 1/20 0.43
▸ PIK3CD O00329 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.39
▸ CASR P41180 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrrolidine SCHEMBL9622388 0.89 ELANE (0.40) ARKDM4EHSD17B10ALDH1A1POLB
SCHEMBL6953743 0.79 PIK3CD (0.40) KDM4EHSD17B10PIK3CDTDP1PARP15
SCHEMBL3069941 0.79 PIK3CD (0.47) ARKDM4EHSD17B10PIK3CDTDP1
SCHEMBL7070839 0.79 KDM4E (0.50) ARKDM4EHSD17B10PIK3CDTDP1
SCHEMBL8057185 0.77 CA12 (0.44) KDM4EHSD17B10ALDH1A1PIK3CDTDP1
SCHEMBL3088454 0.76 PIK3CD (0.51) ARKDM4EHSD17B10PIK3CDTDP1
SCHEMBL5179312 0.76 PIK3CD (0.40) ARKDM4EHSD17B10ELANEPIK3CD
SCHEMBL3090005 0.75 PIK3CD (0.53) ARKDM4EHSD17B10ALDH1A1PIK3CD
SCHEMBL3277310 0.75 HSD17B10 (0.46) KDM4EHSD17B10ALDH1A1POLBPIK3CD
SCHEMBL6955664 0.74 IP6K1 (0.43) ARKDM4EPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2596119-A2 METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS Advanced Cell Technology, Inc. (US) 2013-05-29 — — EP claimed
WO-2012012803-A2 METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS ADVANCED CELL TECHNOLOGY, INC. (US) 2012-01-26 — — WO claimed
US-6322992-B1 CONTACTING FLUID SAMPLE SUSPECTED OF CONTAINING SPECIFIC BINDING LIGAND WITH AN ANALYTIC ELEMENT CONTAINING VANADIUM BROMOPEROXIDASE-LABELED LIGAND OR ANALOG, AND IMMOBILIZED RECEPTOR THAT BINDS LIGAND OR ANALOG; APPLYING WASH SOLUTION JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. 2001-11-27 — — US claimed
EP-0848819-B1 ANALYTICAL ELEMENT AND METHOD FOR THE DETERMINATION OF A SPECIFIC BINDING LIGAND USING A VANADIUM BROMOPEROXIDASE AS A SIGNAL-GENERATING ENZYME ORTHO CLINICAL DIAGNOSTICS INC (US) 2000-04-26 — — EP claimed
EP-0892855-A1 USE OF VANADIUM BROMOPEROXIDASE AS A SIGNAL-GENERATING ENZYME FOR CHEMILUMINESCENT SYSTEMS: TEST KITS AND ANALYTICAL METHODS Ortho-Clinical Diagnostics, Inc. (US) 1999-01-27 — — EP claimed
US-5811253-A Use of vanadium bromoperoxidase as a signal-generating enzyme for chemiluminescent systems: test kits and analytical methods JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1998-09-22 — — US claimed
EP-0848819-A1 ANALYTICAL ELEMENT AND METHOD FOR THE DETERMINATION OF A SPECIFIC BINDING LIGAND USING A VANADIUM BROMOPEROXIDASE AS A SIGNAL-GENERATING ENZYME Ortho-Clinical Diagnostics, Inc. (US) 1998-06-24 — — EP claimed
WO-1997009447-A1 USE OF VANADIUM BROMOPEROXIDASE AS A SIGNAL-GENERATING ENZYME FOR CHEMILUMINESCENT SYSTEMS: TEST KITS AND ANALYTICAL METHODS JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1997-03-13 — — WO claimed
WO-1997009619-A1 ANALYTICAL ELEMENT AND METHOD FOR THE DETERMINATION OF A SPECIFIC BINDING LIGAND USING A VANADIUM BROMOPEROXIDASE AS A SIGNAL-GENERATING ENZYME JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1997-03-13 — — WO claimed
US-5372931-A Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods EASTMAN KODAK COMPANY (US) 1994-12-13 — — US claimed
US-5279940-A Containing 2,3-dihydro-1,4-phthalazinedione, cationic surfactant, and 4*-hydroxyacetanilide EASTMAN KODAK COMPANY (US) 1994-01-18 — — US claimed
EP-4325210-A1 COMPOSITION, STABILIZATION METHOD, METHOD FOR MEASURING AMOUNT OF LUMINESCENCE, AND STABILIZER FOR LUMINESCENT SUBSTRATE FUJIFILM Corporation (JP) 2024-02-21 — — EP disclosed
US-20240043742-A1 COMPOSITION, STABILIZATION METHOD, METHOD FOR MEASURING AMOUNT OF LUMINESCENCE, AND STABILIZER FOR LUMINESCENT SUBSTRATE FUJIFILM CORPORATION (JP) 2024-02-08 — — US disclosed
US-11879148-B2 Methods for detection, determination, and activity measurement of peroxidase based on chemiluminescence KYOTO LUMINOUS SCIENCE LABORATORY (JP) 2024-01-23 — — US disclosed
WO-2009055794-A1 METHOD AND COMPOSITIONS FOR POLYMER NANOCARRIERS CONTAINING THERAPEUTIC MOLECULES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-04-30 — — WO disclosed
US-5279940-A Containing 2,3-dihydro-1,4-phthalazinedione, cationic surfactant, and 4*-hydroxyacetanilide EASTMAN KODAK COMPANY (US) 1994-01-18 — — US disclosed
US-5206149-A Reaction of peroxidase, oxidant, luminol and 2-hydroxy-9-fluorenone enhancer; chemiluminescence TORAY INDUSTRIES, INC. (JP) 1993-04-27 — — US disclosed
US-5106732-A Using oxazole or thiazole derivative TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-04-21 — — US disclosed
EP-0384271-A2 Method for enhancement of chemiluminescence WAKO PURE CHEMICAL INDUSTRIES LTD (JP) 1990-08-29 — — EP disclosed
EP-0134707-B1 METHOD OF ASSAYING THE ACTIVITY OF CELLS TORAY INDUSTRIES, INC. (JP) 1988-12-07 — — EP disclosed
Send feedback